Radionuclide imaging in ischaemic heart failure

British Medical Bulletin

Volumn 92, Issue 1, 2009, Pages 43-59

  Stirrup, James ^a   Maenhout, Annelies ^a   Wechalekar, Kshama ^a   Anagnostopoulos, Constantinos ^b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Coronary artery disease; Myocardial perfusion scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; AMMONIA N 13; ANNEXIN 5 TECHNETIUM 99M; CATECHOLAMINE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HYDROXYEPHEDRINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; NORADRENALIN DERIVATIVE; RADIOISOTOPE; RUBIDIUM CHLORIDE RB 86; TECHNETIUM 99M; TETROFOSMIN; TETROFOSMIN TC 99M; THALLIUM 201; UNCLASSIFIED DRUG; WATER;

ANGIOGENESIS; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EVIDENCE BASED PRACTICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MYOCARDIAL HIBERNATION; MYOCARDIAL PERFUSION SCINTIGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE VENTRICULOGRAPHY; REVIEW; RISK ASSESSMENT; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL; STUNNED HEART MUSCLE;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 72049117699     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldp029     Document Type: Review

References (55)

1. Dickstein K, Cohen-Solal A, Filippatos G et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 29, 2388-2442.
2. Stirrup J, Wechalekar K, Maenhout A, Anagnostopoulos C (2009) Cardiac radionuclide imaging in stable coronary artery disease and acute coronary syndromes. Br Med Bull, 89, 63-78.
3. Brindis RG, Douglas PS, Hendel RC et al. (2005) ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol, 46, 1587-1605.
4. Slart RH, Bax JJ, de Jong RM et al. (2004) Comparison of gated PET with MRI for evaluation of left ventricular function in patients with coronary artery disease. J Nucl Med, 45, 176-182.
5. Hesse B, Lindhardt TB, Acampa W et al. (2008) EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging, 35, 851-885.
6. Wackers FJ, Berger HJ, Johnstone DE et al. (1979) Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol, 43, 1159-1166.
7. Nichols KJ, Van TA, Wang Y, Palestro CJ, Reichek N (2009) Validation of gated blood-pool SPECT regional left ventricular function measurements. J Nucl Med, 50, 53-60.
8. Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation, 66, 1146-1149.
9. Ambrosio G, Betocchi S, Pace L et al. (1996) Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation, 94, 2455-2464.
10. Camici PG, Wijns W, Borgers M et al. (1997) Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation, 96, 3205-3214.
11. Pagano D, Fath-Ordoubadi F, Beatt KJ, Townend JN, Bonser RS, Camici PG (2001) Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium. Heart, 85, 208-212.
12. Vanoverschelde JL, Wijns W, Depre C et al. (1993) Mechanisms of chronic regional postis-chemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation, 87, 1513-1523.
13. Underwood SR, Bax JJ, vom DJ et al. (2004) Imaging techniques for the assessment of myo-cardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J, 25, 815-836.
14. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH (2001) Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol, 26, 147-186.
15. Camici PG, Prasad SK, Rimoldi OE (2008) Stunning, hibernation, and assessment of myocar-dial viability. Circulation, 117, 103-114.
16. Vanoverschelde JL, Depre C, Gerber BL et al. (2000) Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol, 85, 1432-1439.
17. Bax JJ, Poldermans D, van der Wall EE (2004) Evaluation of hibernating myocardium. Heart, 90, 1239-1240.
18. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW (1993) Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation, 87, 1630-1641.
19. Carluccio E, Biagioli P, Alunni G et al. (2006) Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol, 47, 969-977.
20. Di Carli MF, Asgarzadie F, Schelbert HR et al. (1995) Quantitative relation between myocar-dial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation, 92, 3436-3444.
21. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol, 39, 1151-1158.
22. Sharir T, Germano G, Kang X et al. (2001) Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med, 42, 831-837.
23. Hachamovitch R, Rozanski A, Hayes SW et al. (2006) Predicting therapeutic benefit from myo-cardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol, 13, 768-778.
24. Kallen AJ, Jhung MA, Cheng S et al. (2008) Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Am J Kidney Dis, 51, 966-975.
25. Slart RH, Bax JJ, de BJ et al. (2005) Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging, 32, 972-979.
26. Gunning MG, Anagnostopoulos C, Knight CJ et al. (1998) Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation, 98, 1869-1874.
27. Gunning MG, Anagnostopoulos C, Davies G, Forbat SM, Ell PJ, Underwood SR (1997) Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess left ventricular contraction. J Nucl Med, 38, 438-442.
28. Zipes DP (1990) Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation, 82, 1095-1105.
29. Kammerling JJ, Green FJ, Watanabe AM et al. (1987) Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation, 76, 383-393.
30. Cohn JN, Levine TB, Olivari MT et al. (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med, 311, 819-823.
31. Matsui T, Tsutamoto T, Kinoshita M (2001) Relationship between cardiac 123I-metaiodobenzylguanidine imaging and the transcardiac gradient of neurohumoral actors in patients with dilated cardiomyopathy. Jpn Circ J, 65, 1041-1046.
32. Ajiki K, Murakawa Y, Yanagisawa-Miwa A et al. (1993) Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy. Am J Cardiol, 71, 1316-1320.
33. Ferguson DW, Berg WJ, Sanders JS (1990) Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol, 16, 1125-1134.
34. Yamada T, Shimonagata T, Fukunami M et al. (2003) Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol, 41, 231-238.
35. Jacobson A (2009) The Prognostic Significance of 123I-mIBG Myocardial Scintigraphy in Heart Failure Patients: Results from the Prospective Multicenter International ADMIRE-HF Trial. Presented at the 58th Annual Scientific Session of the American College of Cardiology (ACC).
36. Nishioka SA, Martinelli FM, Brandao SC et al. (2007) Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy. J Nucl Cardiol, 14, 852-859.
37. Knuuti J, Bengel FM (2008) Positron emission tomography and molecular imaging. Heart, 94, 360-367.
38. Taki J, Nakajima K, Matsunari I, Bunko H, Takada S, Tonami N (1995) Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid. Eur J Nucl Med, 22, 1385-1392.
39. Taki J, Nakajima K, Matsunari I et al. (1997) Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med, 38, 1503-1510.
40. Hambye AS, Dobbeleir AA, Vervaet AM, Van den Heuvel PA, Franken PR (1999) BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction. J Nucl Med, 40, 1468-1476.
41. Watanabe K, Takahashi T, Miyajima S et al. (2002) Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina. J Nucl Med, 43, 1476-1481.
42. Boersma HH, Kietselaer BL, Stolk LM et al. (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med, 46, 2035-2050.
43. Narula J, Acio ER, Narula N et al. (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med, 7, 1347-1352.
44. Su H, Spinale FG, Dobrucki LW et al. (2005) Noninvasive targeted imaging of matrix metal-loproteinase activation in a murine model of postinfarction remodeling. Circulation, 112, 3157-3167.
45. Bengel FM, Anton M, Avril N et al. (2000) Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation, 102, 948-950.
46. Lan X, Yin X, Wang R, Liu Y, Zhang Y (2009) Comparative study of cellular kinetics of reporter probe [(131)I]FIAU in neonatal cardiac myocytes after transfer of HSV1-tk reporter gene with two vectors. Nucl Med Biol, 36, 207-213.
47. Chung ES, Leon AR, Tavazzi L et al. (2008) Results of the predictors of response to CRT (PROSPECT) trial. Circulation, 117, 2608-2616.
48. Adelstein EC, Saba S (2007) Scar burden by myocardial perfusion imaging predicts echocar-diographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J, 153, 105-112.
49. Bleeker GB, Kaandorp TA, Lamb HJ et al. (2006) Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation, 113, 969-976.
50. Ypenburg C, Schalij MJ, Bleeker GB et al. (2006) Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. J Nucl Med, 47, 1565-1570.
51. Somsen GA, Verberne HJ, Burri H, Ratib O, Righetti A (2006) Ventricular mechanical dys-synchrony and resynchronization therapy in heart failure: a new indication for Fourier analysis of gated blood-pool radionuclide ventriculography. Nucl Med Commun, 27, 105-112.
52. Fauchier L, Marie O, Casset-Senon D, Babuty D, Cosnay P, Fauchier JP (2002) Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with Fourier phase analysis of radionuclide angioscintigraphy. J Am Coll Cardiol, 40, 2022-2030.
53. Chen J, Garcia EV, Lerakis S et al. (2008) Left ventricular mechanical dyssynchrony as assessed by phase analysis of ECG-gated SPECT myocardial perfusion imaging. Echocardiography, 25, 1186-1194.
54. Trimble MA, Borges-Neto S, Honeycutt EF et al. (2008) Evaluation of mechanical dyssyn-chrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. J Nucl Cardiol, 15, 663-670.
55. Klocke FJ, Baird MG, Lorell BH et al. (2003) ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation, 108, 1404-1418.